StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
HOCL.BO$40.40-2.08%
Fair $40.40+0.0%

HOCL.BO

Hindustan Organic Chemicals Limited

Basic Materials / ChemicalsBSE

$40.40

-0.86 (-2.08%)

Fairly Valued+0.0%Fair Value $40.40Fund rank 30/100 · Data gapFallback financials|
SA 39/D
F-Score: 2/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 20%

FCF escenarios

weak_data · normalized FCF $-668.0M · quality 55.3/100

Data gap 30/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 25/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

39/100

D

Piotroski

2/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Sector-specific commodity mid-cycle model required: targets are disabled until normalized cycle price/cost-curve/reserve data exists. ROE is -1.2%, below the 5% threshold
Thesis & Journal · HOCL.BOLocal privado en este navegador · Hindustan Organic Chemicals Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$2.7B

P/E

N/A

•

EV/EBITDA

65.5x

↑

ROE

-1.2%

↓

Gross Margin

28.4%

↑

Debt/Equity

0.28

↑
52-Week Range$40
$21$47

TradingView lightweight chart

HOCL.BO price, volumen y niveles de valoración

Último $40.40Periodo +145.6%
Fair value: $40.40

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2023–2026 · 3 años de histórico normalizado

Revenue CAGR

-3.1%

FCF CAGR

—

FCF margin

-12.6%

FCF / Net income

5.68x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $5.74B · net income $-127.3M · FCF $-723.5M

2023-FY → 2026-FY

Gross margin

28.4%+0.4% pts

Operating margin

-3.4%-4.3% pts

Net margin

-2.2%+6.2% pts

FCF margin

-12.6%-10.4% pts
MetricTTM
2026
2025
2024
2023
Income Statement
Revenue$5.74B$5.74B$5.36B$7.04B$6.31B
Net Income$-127.3M$-127.3M$3.92B$-546.2M$-533.9M
EBITDA$85.0M$85.0M$4.39B$156.0M$171.6M
EPS——58.33-8.05-8.24
Gross Margin28.4%28.4%21.8%27.1%28.0%
Operating Margin-3.4%-3.4%-16.4%-0.1%0.9%
Net Margin-2.2%-2.2%73.1%-7.8%-8.5%
Balance Sheet
Debt/Equity0.280.280.20-10.97-10.83
Current Ratio3.603.60———
Cash Flow
Free Cash Flow$-723.5M$-723.5M$6.24B$-668.0M$-137.7M
Returns
ROE-1.2%-1.2%37.5%106.2%106.2%
Valuation
P/E——0.68——
EV/EBITDA65.4665.461.0756.0341.52
P/B0.260.260.25——
Growth & Yield
Revenue Growth7.1%7.1%-23.9%11.5%—
EPS Growth——824.6%2.3%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +17.2%

Total return

+17.2%

Start / end P/E

n/dx → n/dx

EPS bridge

58.33 → n/d

Residual

+17.2%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term+17.2%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.